ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1958

Longitudinal analysis on imaging outcomes: should we use the individual scores from multiple readers or rather the consensus or average of readers?

Liese de Bruin1, Floris A. van Gaalen1, Manouk de Hooge2, Miranda van Lunteren1, Mary Lucy Marques3, Monique Reijnierse4, Roberta Ramonda5, Inger Jorid Berg6, Carl Turesson7, Robert Landewé8, Désirée Van Der Heijde1 and Sofia Ramiro9, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Rheumatology, Ghent University Hospital, Ghent, Belgium, 3Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands; and Coimbra Local Health Unit, Coimbra, Portugal, 4Department of Radiology, Leiden University Medical Center, Leiden, Netherlands, 5Rheumatology Unit-DIMED-University of Padova ITALY, Padova, Padua, Italy, 66Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Nepal, 7Lund University, Malmö, Sweden, 8Department of Rheumatology, Amsterdam University Medical Center, Amsterdam, Netherlands; and Zuyderland Medical Center, Heerlen, Netherlands, 9Leiden University Medical Center, Bunde, Netherlands

Meeting: ACR Convergence 2025

Keywords: Imaging, longitudinal studies, spondyloarthritis, Statistical methods

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1936–1971) Imaging of Rheumatic Diseases Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Imaging outcomes are often evaluated using longitudinal analysis based on scores from multiple readers. However, the input into the analysis can vary from the scores of multiple individual readers to using a consensus or average across multiple readers. We assessed if this choice at the analysis stage can result in different estimates of change, we performed longitudinal analyses on different imaging outcomes in patients with early axial SpA (axSpA), using both individual reader scores and consensus scores/averages of readers.

Methods: Patients with chronic back pain (³3 months; ≤2 years; onset < 45 years) from the SPondyloArthritis Caught Early cohort with a rheumatologist’s diagnosis of axSpA at the 2-year follow-up were included. MRIs and radiographs of the sacroiliac joints and spine were obtained at baseline, 3 months, 1 and 2 years of follow-up and afterwards scored for inflammatory and structural lesions by 3 central readers, except for the MRI spine (2 readers). Patients included in this analysis had ≥1 score from ≥1 reader at 2-year follow-up. Each outcome was analyzed per reader and also according to the consensus (³2 readers) or average across readers. Change over time was analyzed with generalized estimating equations, with ‘time’ as explanatory variable. For the analysis per individual reader, a multilevel analysis was performed, taking each individual reader into account. For the analysis of the consensus/average scores, each outcome was modelled according to its consensus/average score across readers.

Results: In total we analyzed 279 patients with axSpA (mean age 31 (SD 8) years; 53% males). As shown in Table 1, change estimates for continuous scores were very similar based on individual reader scores and using average scores across readers. However, larger discrepancies were found when comparing change estimates for dichotomous variables, expressed as yearly percentage change (Table 2).Overall, the difference between the analytical choices could go in both directions. Spinal change was underestimated using the consensus scores of dichotomous variables, while change scores of the dichotomous variables in SIJ were mostly overestimated, especially of variables including erosions. In dichotomous variables, percentual differences between change scores calculated according to both analytical methods ranged from -35.4 to 37.5%.

Conclusion: The seemingly simple decision of how to incorporate imaging outcomes from multiple readers into a model of change over time can significantly influence the final estimates, especially when dealing with dichotomous outcomes. To minimize the risk of introducing bias at the analytical stage, multilevel analyses that account for individual reader scores are recommended, rather than relying on pre-calculated consensus scores. This analysis also shows the vulnerability of dichotomous outcomes, reinforcing the disposition to use continuous measures as outcomes in analyses.

Supporting image 1

Supporting image 2


Disclosures: L. de Bruin: None; F. van Gaalen: AbbVie, 2, BMS, 2, Eli Lilly, 2, Jacobus Stichting, 5, MSD, 2, Novartis, 2, 5, Stichting ASAS, 5, Stichting vrienden van Sole Mio, 5, UCB, 5; M. de Hooge: UCB pharma, 2; M. van Lunteren: None; M. Marques: Novartis, 2, 6; M. Reijnierse: None; R. Ramonda: None; I. Berg: None; C. Turesson: AbbVie/Abbott, 1, 6, Nordic Drugs, 2, 6, Novartis, 1, 6; R. Landewé: AbbVie/Abbott, 2, Bristol-Myers Squibb(BMS), 2, Eli Lilly, 2, Janssen, 2, Joint Imaging BV, 12, Director, Novartis, 2, Pfizer, 2, Rheumatology Consultancy BV, 12, Director, UCB, 2; D. Van Der Heijde: AbbVie, 2, Alfasigma, 2, Annals of the Rheumatic Diseases, 12, Associate editor, ArgenX, 2, Bristol Myers Squibb, 2, Eli Lilly and Company, 2, Grey-Wolf Therapeutics, 2, Imaging Rheumatology BV, 12, Director, Janssen, 2, Journal of Rheumatology, 12, Editorial board member, Novartis, 2, Pfizer, 2, RMD Open, 12, Editoral board member, Takeda, 2, UCB, 2; S. Ramiro: AbbVie, 2, 5, Eli Lilly, 2, 5, Galapagos/Alfasigma, 2, 5, Janssen, 2, MSD, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Sanofi, 2, 5, UCB, 2, 5.

To cite this abstract in AMA style:

de Bruin L, van Gaalen F, de Hooge M, van Lunteren M, Marques M, Reijnierse M, Ramonda R, Berg I, Turesson C, Landewé R, Van Der Heijde D, Ramiro S. Longitudinal analysis on imaging outcomes: should we use the individual scores from multiple readers or rather the consensus or average of readers? [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/longitudinal-analysis-on-imaging-outcomes-should-we-use-the-individual-scores-from-multiple-readers-or-rather-the-consensus-or-average-of-readers/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/longitudinal-analysis-on-imaging-outcomes-should-we-use-the-individual-scores-from-multiple-readers-or-rather-the-consensus-or-average-of-readers/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology